Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced the exclusive launch of generic Viread tablets 300 mg in the U.S.
read more
Wednesday, December 18, 2019
Tetra Bio-Pharma announced the signing of a definitive agreement with Azevedos Indústria Farmacêutica for the marketing and distribution of CAUMZTM in Portugal.
read more
Tetra has awarded the contract for the manufacturing of its API, HU-308, and of the intravenous, sterile, finished drug product ARDS-003 to Dalton.
read more
Friday, December 01, 2017
TesoRx and ASKA have expanded their existing collaboration to develop and commercialize TesoRx's novel oral testosterone product, TSX-011.
read more
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and ...
read more
Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
read more
Tergus Pharma has announced a 100,000-square-foot building for its new headquarters and plans to invest to expand into commercial manufacturing.
read more
Tuesday, September 23, 2014
Tergus (www.terguspharma.com) has acquired cutting-edge equipment that will aid in manufacturing topical pharmaceutical supplies for clinical trials. The company, currently working from a state-of-the-art facility at Research Triangle Park area of ...
read more
Friday, December 20, 2013
Temptime Corporation, the world’s leading
provider of time-temperature indicators to the health care industry, announced today that it
has acquired Enfield, Conn.-based William Laboratories to expand into blood temperature
monitoring solutions. ...
read more
Telstar has arranged a technical seminar (Istanbul, 2013 May 28th) to provide insight into the latest innovations and trends in high-technology process equipment solutions and project services of engineering, construction and consultancy for the life...
read more
On June 18, 2013 a Technical Conference on Sterile Manufacturing, organized by ISPE Spain, will be held at Telstar’s Corporate Headquarters and Life Sciences facility in Terrassa (Barcelona). This conference is focused on the latest developments in ...
read more